Hepatoblastoma

Hepatoblastoma click to access explanations in the original CAP template

This is additional protocol for biopsy specimen.

OPTIONAL: Expert Consultation before completion of the reporting.

Gross data elements:

- Procedure:
- Tumor site:
+ Tumor focality (within liver):
+ Macroscopic Extent of Tumor:	Tumor confined to liver Tumor extends into adjacent organ(s) (specify): Tumor extends into adjacent soft tissue, Diaphragm Tumor extends into adjacent soft tissue, Abdominal wall Tumor extends into adjacent soft tissue, other (specific): Intraoperative tumor spill Gross tumor rupture, preoperative Cannot be determined
+ Serum alpha fetoprotein level:
- Tumor size:

Microscopic descriptions:

- Tumor histology and immunohistochemical studies:

- Histologic type:
- Preoperative treatment history:
+ Treatment effect:
+ Macroscopic Vascular invasion:
+ Microscopic Lymphatic and / or vascular invasion:
+ Perineural invasion:
+ INI1 IHC performed:
+ Glypican-3 IHC performed:
+ Beta-catenin IHC performed:

Surgical margins:

Regional lymph nodes:

- Number of regional lymph nodes examined:
- Number of lymph nodes involved (specify locations):
- Extranodal extension:
- Size of largest metastatic deposit (mm), specify site:
- Size of largest lymph node involved (mm), specify site:

Distant Metastasis: Not applicable Not identified Interior phrenic lymph node(s): Lymph node(s) distal to hilum: Hepatoduodenal ligament lymph node(s): Caval region lymph node(s): Other (specify): Cannot be determined: + Histologic Type Present in Distant Metastasis:

No pathologic staging system is clinically applicable in hepatoblastoma. PRETEXT/PROTEXT staging based on CT and MRI findings might be included (supplanting COG staging).

+ Additional pathologic findings:

No background liver available for evaluation None identified Cirrhosis/fibrosis (specify stage of fibrosis): Iron overload Hepatitis (specify type):

- Other (specify):

- Additional notes: